- Home
- RIGL vs ONTF Comparison
RIGL vs ONTF Comparison
Compare RIGL & ONTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- ONTF
- Stock Information
- Founded
- RIGL 1996
- ONTF 1998
- Country
- RIGL United States
- ONTF United States
- Employees
- RIGL N/A
- ONTF N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- ONTF Computer Software: Prepackaged Software
- Sector
- RIGL Health Care
- ONTF Technology
- Exchange
- RIGL Nasdaq
- ONTF Nasdaq
- Market Cap
- RIGL 247.1M
- ONTF 273.3M
- IPO Year
- RIGL 2000
- ONTF 2021
- Fundamental
- Price
- RIGL $25.04
- ONTF $6.42
- Analyst Decision
- RIGL Buy
- ONTF Hold
- Analyst Count
- RIGL 5
- ONTF 3
- Target Price
- RIGL $31.30
- ONTF $8.00
- AVG Volume (30 Days)
- RIGL 288.9K
- ONTF 105.1K
- Earning Date
- RIGL 11-07-2024
- ONTF 11-07-2024
- Dividend Yield
- RIGL N/A
- ONTF N/A
- EPS Growth
- RIGL N/A
- ONTF N/A
- EPS
- RIGL 0.22
- ONTF N/A
- Revenue
- RIGL $157,374,000.00
- ONTF $150,738,000.00
- Revenue This Year
- RIGL $38.26
- ONTF N/A
- Revenue Next Year
- RIGL $24.21
- ONTF N/A
- P/E Ratio
- RIGL $109.79
- ONTF N/A
- Revenue Growth
- RIGL 21.65
- ONTF N/A
- 52 Week Low
- RIGL $7.48
- ONTF $5.37
- 52 Week High
- RIGL $29.82
- ONTF $8.35
- Technical
- Relative Strength Index (RSI)
- RIGL 68.80
- ONTF 52.89
- Support Level
- RIGL $22.33
- ONTF $6.16
- Resistance Level
- RIGL $29.16
- ONTF $6.75
- Average True Range (ATR)
- RIGL 2.30
- ONTF 0.24
- MACD
- RIGL 0.41
- ONTF -0.01
- Stochastic Oscillator
- RIGL 69.96
- ONTF 64.09
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences, and multimedia content experiences. The company derives revenue from subscription agreements with customers for accessing the platform and related services. Geographically, it derives a majority of revenue from the United States.